WHO ICTRP trial
Evaluation of the efficacy and safety of splenic artery infusion chemotherapy as…
ChiCTR2500107417 · Chinese Clinical Trial Registry (ChiCTR) · Recruiting
Key facts
| Trial ID | ChiCTR2500107417 |
|---|---|
| Public title | Evaluation of the efficacy and safety of splenic artery infusion chemotherapy as a preoperative conversion treatment option for locally advanced or liver oligometastatic pancreatic body and tail cancer: A single-arm, phase II clinical study |
| Scientific title | Evaluation of the efficacy and safety of splenic artery infusion chemotherapy as a preoperative conversion treatment option for locally advanced or liver oligometastatic pancreatic body and tail cancer: A single-arm, phase II clinical study |
| Primary sponsor | Department of Biliary-Pancreatic Surgery, Sun Yat-sen Memorial Hospital, Sun Yat-sen University |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Recruiting |
| Study type | Interventional study |
| Phase | 2 |
| Countries | China |
| Conditions | Carcinoma of the body and tail of the pancreas |
| Interventions | Splenic artery perfusion group:Splenic arterial perfusion chemotherapy (NCCN guideline recommendation: AG or FOLFIRINOX), 3 weeks is a treatment cycle, 6 courses |
| Registration date | Aug 11, 2025 |
| Target size | Splenic artery perfusion group:44 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: